CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Noninvasive Nuclear SPECT Myocardial Blood Flow Quantitation to Guide Management for Coronary Artery Disease Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention Raising the Evidentiary Bar for Guideline Recommendations for TAVR: JACC Review Topic of the Week Routine Continuous Electrocardiographic Monitoring Following Percutaneous Coronary Interventions The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study New-onset atrial fibrillation after PCI and CABG for left main disease: insights from the EXCEL trial and additional studies Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial

Clinical Case Study2017 Sep;42(9):e400-e402.

JOURNAL:Clin Nucl Med. Article Link

Noninvasive Nuclear SPECT Myocardial Blood Flow Quantitation to Guide Management for Coronary Artery Disease

Chen LC, Jong BH, Lin SC et al. Keywords: myocardial blood flow quantitation; dynamic SPECT; multivessel coronary artery disease; myocardial perfusion

ABSTRACT

Recently, myocardial bloodflow quantitation with dynamic SPECT has been validated to enhance the detection of multivessel coronary artery disease (CAD) and conclude equivocal SPECT myocardial perfusion study. This advance opened an important clinical application to utilize the tool in guiding CAD management for area where myocardial perfusion tracers for PET are unavailable or unaffordable. We present a clinical patient with ongoing recursive angina who underwent multiple nuclear stress tests for a sequence of CAD evaluation in 26 months and demonstrated that SPECT myocardial bloodflow quantitation properly guided CAD management to warrant patient outcome.